> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# PharMEDium Recalls Drug Products After Review
- URL: https://www.fdaweb.com/pharmedium-recalls-drug-products-after-review/
- Published: 2018-01-03T12:00:00.000Z
- Updated: 2026-09-14T23:10:28.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5140405

PharMEDium Services has recalled [several lots](https://www.fda.gov/Safety/Recalls/ucm590941.htm?ref=fdaweb.com) of drug products to the hospital/user level due to a lack of sterility assurance. “PharMEDium conducted a retrospective review of all commercially distributed product lots compounded in the Memphis location currently within their labeled expiration date in response to an FDA request regarding microbial control program during recent inspection to provide verification of acceptable microbiological testing results of the ISO5 environment, personnel glove sampling results, media fill results, sterility testing results, and endotoxin results,” a [recall notice ](https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm591048.htm?utm%5Fcampaign=Compounded%20Sterile%20Products%20by%20PharMEDium%20Services%3A%20Recall&utm%5Fmedium=email&utm%5Fsource=Eloqua)says. The review indicated that a total of 55 lots of different products impacting 25,327 units had two unsuccessful media fills. The remaining lots were associated with environmental monitoring or personnel monitoring “excursions,” the notice says.